03-2919. Manufacturer of Controlled Substances; Notice of Application  

  • Start Preamble

    Pursuant to § 1301.33(a) of title 21 of the Code of Federal Regulations (CFR), this is notice that on October 23, 2002, AccuStandard, Inc., 125 Market Street, New Haven, Connecticut 06513, made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

    DrugSchedule
    Cathinone (1235)I
    Methcathinone (1237)I
    Aminorex (1585)I
    Gamma hydroxybutyric acid (2010)I
    Metaqualone (2565)I
    Ibogaine (7260)I
    Lysergic acid diethylamide (7315)I
    Tetrahydrocannabinols (7370)I
    Mescaline (7381)I
    4-Bromo-2,5-dimethoxyamphetamine (7391)I
    4-Bromo-2,5-dimethoxyphenethylamine (7392)I
    4-Methyl-2,5-dimethoxyamphetamine (7395)I
    2,5-Dimethoxyamphetamine (7396)I
    3,4-Methylenedioxyamphetamine (7400)I
    N-Hydroxy-3,4-methylenedioxyamphetamine (7402)I
    3,4-Methylenedioxy-N-ethylamphetamine (7404)I
    3,4-Methylenedioxymethamphetamine (7405)I
    4-Methoxyamphetamine (7411)I
    Bufotenine (7433)I
    1-[1-(2-Thienyl)cyclohexyl]piperidine (7470)I
    Codeine-N-oxide (9053)I
    Dihydromorphine (9145)I
    Start Printed Page 6182
    Heroin (9200)I
    Morphine-N-oxide (9307)I
    Normorphine (9313)I
    Etonitazene (9624)I
    Amphetamine (1100)II
    Methamphetamine (1105)II
    Phenmetrazine (1631)II
    Methylphenidate (1724)II
    Amobarbital (2125)II
    Pentobarbital (2270)II
    Secobarbital (2315)II
    Glutethimide (2550)II
    Phencyclidine (7471)II
    Alphaprodine (9010)II
    Anileridine (9020)II
    Cocaine (9041)II
    Codeine (9050)II
    Diprenorphine (9058)II
    Dihydrocodeine (9120)II
    Hydromorphone (9150)II
    Diphenoxylate (9170)II
    Benzoylecgonine (9180)II
    Ecgonine (9180)II
    Hydrocodone (9193)II
    Levorphanol (9220)II
    Methadone (9250)II
    Morphine (9300)II
    Thebaine (9333)II
    Opium, raw (9600)II
    Opium tincture (9630)II
    Opium powdered (9639)II
    Levo-alphacetylmethadol (9648)II
    Oxymorphone (9652)II
    Alfentanil (9737)II
    Sufentanil (9740)II
    Fentanyl (9801)II

    The firm plans to manufacture small quantities of the listed controlled substances to make reference standards.

    Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.

    Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register, Representative (CCR), and must be filed no later then April 7, 2003.

    Start Signature

    Dated: January 27, 2003.

    Laura M. Nagel,

    Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

    End Signature End Preamble

    [FR Doc. 03-2919 Filed 2-5-03; 8:45 am]

    BILLING CODE 4410-09-M

Document Information

Published:
02/06/2003
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
03-2919
Pages:
6181-6182 (2 pages)
PDF File:
03-2919.pdf